# Tempest Therapeutics (TPST) — Analyst Forecast

TPST · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tpst/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 1 | 0 | 0 | 1 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Jan 22, 2026 | HC Wainwright & Co. | Upgraded | Neutral → Buy | $11.00 |
| Apr 10, 2025 | HC Wainwright & Co. | Downgraded | Buy → Neutral | $16.00 |
| Apr 10, 2025 | Scotiabank | Downgraded | Sector Outperform → Sector Perform | $9.00 |
| Mar 28, 2025 | HC Wainwright & Co. | Maintained | Buy | $16.00 |
| Mar 28, 2025 | Scotiabank | Maintained | Sector Outperform | $7.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Nov 13, 2024 | Piper Sandler | Maintained | Overweight | $5.00 |
| Oct 10, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Aug 15, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Jun 21, 2024 | Piper Sandler | Maintained | Overweight | $8.00 |
| Jun 20, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Mar 20, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Mar 14, 2024 | Scotiabank | Initiated Coverage | Sector Outperform | $13.00 |
| Mar 13, 2024 | Scotiabank | Initiated Coverage | Sector Outperform | $13.00 |
| Mar 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $47.00 |
| Feb 8, 2024 | Jefferies | Initiated Coverage | Buy | $15.00 |
| Oct 11, 2023 | HC Wainwright & Co. | Maintained | Buy | $47.00 |

## Frequently Asked Questions

### Is TPST a buy, sell, or hold?

Analysts covering Tempest Therapeutics currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on TPST?

On Sep 24, 2026, HC Wainwright & Co. maintained Tempest Therapeutics at Buy with a price target of $7.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).